Hemos Bio was invited to attend the 6th SynBio China Conference on Synthetic Biology and Biomanufacturing, where General Manager Huang Gang delivered a keynote speech.

On May 27–28, the 6th SynBio China Conference on Synthetic Biology and Biomanufacturing was successfully held in Beijing.

As a premier industry event in China’s synthetic biology and biomanufacturing sectors, this conference brings together over a thousand industry leaders, research experts, and corporate representatives from fields including synthetic biology, biomanufacturing, and the beauty and personal care industries. Focusing on cutting-edge trends across multiple domains—such as food, materials, beauty and personal care, pharmaceuticals, AI technologies, and biomanufacturing processes—the event explores pathways for integrating biomanufacturing innovation with industrial applications, injecting fresh momentum into the sector’s high‑quality development.

Mr. Huang Gang, General Manager of Hemos Bio, was invited to attend and delivered a speech at the “Daily Chemical Beauty Care and Innovative Ingredients Forum.” “Recombinant Humanized Keratin (RHK): A World-Leading Biomaterial with Multi-Scenario Applications” In the keynote speech, Hemos Bioscience systematically shared its nearly 20-year experience in the field of Recombinant Keratin. Technological accumulation, core breakthroughs, and innovative achievements , showcasing the innovative strength and global competitiveness of China’s domestically developed biomaterials.

In his speech, Mr. Huang Gang provided an in-depth analysis of Recombinant Keratin from R&D, efficacy validation, scenario-based applications, and industrial-scale implementation The end-to-end development roadmap. Leveraging Hemos’ cutting-edge production processes and technological systems, the company has successfully overcome technical challenges, achieving large-scale mass production of Recombinant Keratin, and in Hair care, skin care, oral care It has successfully validated efficacy and enabled market applications across various fields, providing a practical yet forward-looking solution for the innovative R&D and industrial translation of functional ingredients in the beauty and personal care sectors.

In the future, Hemos Bioscience will continue to focus on core technological innovation in biomanufacturing, deepen its expertise in the field of Recombinant Keratin, steadily advance technological iteration and upgrades, and accelerate the scaling-up and commercialization of its research achievements.

Meanwhile, enterprises will proactively collaborate with upstream and downstream partners across the industry, deepen industry–university–research collaboration and foster in-depth industrial partnerships, continuously empowering the beauty and personal care sector to upgrade toward greener practices, enhanced efficacy, and premium positioning, while steadily driving innovation and development in China’s bio-manufacturing industry.